Titelbild von BASF Pharma SolutionsBASF Pharma Solutions
BASF Pharma Solutions

BASF Pharma Solutions

Arzneimittelherstellung

Inspiring Medicines for better Lives

Info

BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of industry experts and digital solutions, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, we have the knowledge and resources to make pharmaceutical drug delivery and the manufacturing of drugs and biologics safer and more sustainable. We create solutions for Biopharma, Parenteral, Oral, Solubilization and Topical applications and are also a leading supplier of selected APIs such as ibuprofen, L-menthol and Omega-3. About BASF At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Further information at www.basf.com. Credits: https://www.basf.com/en/tools/legal/credits.html Data protection information: https://www.basf.com/global/en/legal/data-protection-at-basf.html

Website
http://www.pharma.basf.com
Branche
Arzneimittelherstellung
Größe
10.001+ Beschäftigte
Hauptsitz
Ludwigshafen am Rhein
Gegründet
1865
Spezialgebiete
Pharmaceutical Excipients, Active Pharmaceutical Ingredients, Omega-3 Fatty Acids, Solubilization, Skin Delivery, Biologic Solutions, Instant & Modified Release, Softgels, Regulatory Support, Safety, Technical Support, Product Formulation, compliance documentation, Topicals, Virtual Assistants, Orals, Omega 3 und BioPharma

Updates

  • Big thanks to MEGGLE Excipients for spotlighting this collaboration! The Production Cost Calculation & Comparison app is a great example of what happens when complementary expertise comes together to create practical value for drug product development. Building on MEGGLE’s DirectCost app, we worked side by side to integrate and further develop the solution as part of ZoomLab® - our digital platform for drug product development. It’s exactly the kind of ecosystem we want to foster - combining expertise, tools and partner capabilities to help our customers address formulation challenges more efficiently. At BASF Pharma Solutions, we believe ZoomLab® is a platform that connects scientific expertise with industry know-how to create tangible value across the Pharma market. We truly appreciate the partnership with MEGGLE and look forward to continuing this journey together. Learn more about ZoomLab® and sign up for free access: zoomlab.com

    Unternehmensseite für MEGGLE Excipients anzeigen

    5.550 Follower:innen

    📢 𝗢𝘂𝗿 𝗰𝗼𝘀𝘁-𝗰𝗮𝗹𝗰𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘁𝗼𝗼𝗹 "𝗗𝗶𝗿𝗲𝗰𝘁𝗖𝗼𝘀𝘁" 𝗵𝗮𝘀 𝗲𝘃𝗼𝗹𝘃𝗲𝗱 𝗮𝗻𝗱 𝗶𝘀 𝗻𝗼𝘄 𝗽𝗮𝗿𝘁 𝗼𝗳 *𝗭𝗼𝗼𝗺𝗟𝗮𝗯®. Production costs depend on multiple factors. Process time, equipment, batch size and individual manufacturing steps can all have a significant impact on the overall cost of a pharmaceutical formulation. MEGGLE Excipients and BASF Pharma Solutions have further developed the former "DirectCost" tool and integrated it into ZoomLab® as the “𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗖𝗼𝘀𝘁 𝗖𝗮𝗹𝗰𝘂𝗹𝗮𝘁𝗶𝗼𝗻 & 𝗖𝗼𝗺𝗽𝗮𝗿𝗶𝘀𝗼𝗻” 𝗮𝗽𝗽. By combining formulation expertise, industrial manufacturing experience and a powerful digital platform, the app provides greater cost transparency and enables more realistic comparisons of formulations and manufacturing processes. 👉 Learn More: https://lnkd.in/dVqw5Xem 👉 Register for free: https://lnkd.in/dPF4vsVA 👉 Login ZoomLab: https://lnkd.in/gPWncP5C * ZoomLab® is a registered trademark of BASF SE #MEGGLEExcipients #BASF #PharmaceuticalDevelopment #FormulationDevelopment #ProductionCosts #Excipients #Pharma #DigitalTools

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite für BASF Pharma Solutions anzeigen

    21.821 Follower:innen

    📘 New Compendium: Practical Solubilization Strategies for Improving Bioavailability   We’re excited to share a free, downloadable Solubilizer Compendium to help formulators  identify potential solutions for solubility and bioavailability challenges.   You’ll find practical insights you can apply right away, whether you’re selecting excipients or optimizing a delivery approach for a challenging active ingredient. 🚀 What you’ll find inside: • Expert perspectives on common formulation challenges • Practical guidance for selecting and using solubilizers effectively • Real examples and tools to support smarter excipient selection and decision‑making • Clear, concise takeaways at your fingertips If you’re committed to deepening your expertise and staying competitive, download the Solubilizer Compendium and keep it on hand as a quick reference for your next formulation challenge. 👉 Download the Solubilizer Compendium here: https://lnkd.in/ey349qpK We hope it inspires your next breakthrough! #Innovation #Learning #IndustryInsights #Pharmaceuticals

  • CPHI China 2026 | Award & Highlights We’re proud to announce that we were honored with a Pharma Excipients Award in the category “Drug Delivery Empowerment” at CPHI China last week! Our product, Soluplus®, earned the Silver award in recognition of its proven capabilities in supporting new drug development in China. Annegret Welzel, Vice President, GBM Excipients & Biopharma, BASF Pharma Solutions, and our team actively engaged with customers throughout the three-day event. Special thanks to Tomoyoshi Kajiura and our Omega‑3 team members for being onsite, hosting customers, and driving deeper conversations around nitrite‑tested Kollidon® NT grades, BASF’s Omega‑3 APIs portfolio, Kollicoat® MAE polymers for ASDs, and many more innovative solutions. THANK YOU to everyone who visited our booth and interacted with us! Feel free to reach out and continue the conversation or explore how we can support your next formulation challenge: https://pharma.basf.com/ #CPHI #Pharma #Soluplus #DrugDelivery #Award

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
      +1
  • BASF Pharma Solutions hat dies direkt geteilt

    Yesterday, I had the opportunity to join several of the BASF Pharma Solutions technical team at DissoAmerica 2026, held by the US Chapter of the Society for Dissolution Science. It was a great conference with presentations by top scientists from leading pharmaceutical companies and a very informative session by the US FDA. A real highlight for me was the excellent presentation by Sandip Tiwari, BASF (pictured) on Bioavailability Correlations in Lipid-Based formulations

    • Kein Alt-Text für dieses Bild vorhanden
  • 🔷 Kollicoat® Experience Center Workshop | BASF Innovation Campus, Mumbai On June 9th, we hosted an engaging Kollicoat® Experience Center workshop at the Global Applications Lab, BASF Innovation Campus, Mumbai, together with our valued partner Transchem Corporation Pharma Pvt Ltd. Designed as a highly interactive, application-driven session, the workshop brought together formulation experts to explore modern film coating technologies and their practical implementation. Participants experienced firsthand how film coating science translates into real performance, making the session highly interactive, practical, and impactful.   The dynamic program combined science, formulation strategy, and practical hands-on demonstrations. ✅ Kollicoat® portfolio positioning across IR, SR, DR, and moisture protection applications ✅ Deep dive into Kollicoat® IR based coating applications and the clear performance advantages over conventional coating polymers ✅ Extensive hands-on workstation demonstrations, including: - Film flexibility and performance evaluation - High-efficiency coating processes and wide processing window - Drug layering using fluid bed processing - Seal coating applications for DR/SR systems 🔹 Key highlights A main focus was demonstrating the value of Kollicoat® IR as a next-generation film coating technology in modern pharmaceutical manufacturing: 🔹 High process efficiency – faster coating cycles and improved productivity 🔹 Robust processing – wide operating window enabling consistent scale-up 🔹 Formulation flexibility – adaptable across APIs, cores, and equipment 🔹 Multifunctional use – enabling coating, binding, and drug layering applications 🔹 Superior film properties – flexible, uniform, and elegant coatings We also showcased how digital tools such as ZoomLab® are enabling smarter film coating process design, supporting data-driven development and efficient scale-up. The result: an engaging session highlighting the benefits of advanced film coating technologies such as Kollicoat® IR in meeting evolving industry needs. 👏 A sincere thank you to all participants and our partner Transchem for making this workshop a success! Umakanth Kanna Aditi Poddar, Ph.D Gajanan Awari Rajkiran Narkhede, Ph.D. Tanvi Raorane Dr. Rajkumar Jana

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
      +3
  • We’re pleased to share highlights from our recent technical seminar, “Enabling Differentiated Formulations with Key Functional Excipients”, held in Shanghai. More than 50 pharmaceutical scientists joined us for in-depth discussions and exchanges with experts from BASF Pharma Solutions. The seminar featured valuable insights on modified-release technologies, solubilization strategies and digital formulation design. Highlights included practical perspectives from Umakanth Kanna, Head of Technical Services - Asia Pacific, on solutions for sustained-release formulations, as well as insights from Dr. Xungui He, Chief Scientist & Deputy General Manager of 2Y-Chem, a renowned CRO in China, who shared ASD strategies for NCE formulation development featuring Soluplus®. Our Technical Services team, including kai zhuang, Manager – Technical Services and Application, shared case studies on HME using the Kollicoat® MAE series, and presented additional topics, including solubilization approaches and ZoomLab®, our digital platform for drug product development. Sincere thanks to all our attendees for the active participation and dynamic exchanges that helped make this seminar such a great success. #BASF #PharmaSolutions #Solubilization #Formulation

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
      +8
  • ✨ Unlock the Full Potential of Poloxamers in Pharmaceutical Formulation Formulators are facing increasing complexity—from solubilizing challenging APIs to designing advanced drug delivery systems that perform reliably across dosage forms. Kolliphor® poloxamers are widely used and trusted non-ionic surfactants in modern pharmaceuticals, known for: 🔹 Exceptional solubilization and emulsification performance 🔹 Biocompatibility and excellent tolerability across formulations 🔹 Versatility in injectables, ophthalmics, and thermoreversible gel Find the right solution for your formulation in BASF’s Kolliphor® P Grades guide, featuring: 📌 Detailed product information for standard, micro and bioprocessing grades 📌 Monograph compliance and global certifications 📌 Packaging, stability and handling guidance 📌 Key benefits, including supply reliability, sustainability insights and advanced technical support Whether you're developing complex injectables, optimizing biologics production, or designing next-generation delivery systems, this guide is a practical reference to help guide excipient selection. 👉 Click here to explore the full document: https://lnkd.in/eVZdZc-v #PharmaInnovation #Excipients #DrugDevelopment #Bioavailability #Pharmaceuticals

    • Kein Alt-Text für dieses Bild vorhanden
  • Webinar | Surfactant Strategies for Biopharmaceutical Stability and Performance May 12, 2026 @11:00am EDT Reserve your spot for a data-driven look at surfactant selection for biologics. Surfactants are essential for maintaining the physical stability of therapeutic protein formulations—but commonly used polysorbates can degrade over time, contributing to particle formation and other stability challenges. In this webinar, presenters Damien Bellos, PhD, LSSBB, Nadine Löw and Nadya Morales-Cummings discuss Poloxamer 188 (P188) variants as an alternative surfactant approach—and how surfactant hydrophobicity can impact formulation performance. We’ll share comparative data on: 💠 Aggregation reduction 💠 Protein adsorption to PDMS-containing primary packaging 💠 Avoiding enzymatic degradation pathways commonly associated with polysorbates You’ll also leave with practical guidance for excipient selection to support long-term stability. JOIN US | Register here: https://lnkd.in/erF-M-A3

Verbundene Seiten

Ähnliche Seiten